Immunogenicity of simultaneous versus sequential administration of a 23-valent pneumococcal polysaccharide vaccine and a quadrivalent influenza vaccine in older individuals: A randomized, open-label, non-inferiority trial

Immunogenicity of simultaneous versus sequential administration of a 23-valent pneumococcal polysaccharide vaccine and a quadrivalent influenza vaccine in older individuals: A randomized, open-label, non-inferiority trial

It is unclear whether simultaneous administration of a 23-valent pneumococcal polysaccharide vaccine (PPSV23) and a quadrivalent influenza vaccine (QIV) produces immunogenicity in older individuals. This study tested the hypothesis that the pneumococcal antibody response elicited by simultaneous adm...

Full description

Bibliographic Details
Main Authors: Kei Nakashima, Masahiro Aoshima, Satoko Ohfuji, Satoshi Yamawaki, Masahiro Nemoto, Shinya Hasegawa, Satoshi Noma, Masafumi Misawa, Naoto Hosokawa, Makito Yaegashi, Yoshihito Otsuka
Format: Article
Language:English
Published: Taylor & Francis Group 2018-08-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
23-valent pneumococcal polysaccharide vaccine
quadrivalent influenza vaccine
immunogenicity
simultaneous administration
elderly population
Online Access:http://dx.doi.org/10.1080/21645515.2018.1455476

Internet

http://dx.doi.org/10.1080/21645515.2018.1455476

Similar Items